Test your knowledge and determine where to begin your journey with Learn Immuno-Oncology.
Immunotherapy is a type of treatment designed to improve or boost the body’s natural defenses to fight disease.
The field of immuno-oncology is rapidly expanding, with more than 20 novel therapies approved for the treatment of various cancers over the past few years.
This module discusses currently approved immunotherapeutic agents based on the cancers they are approved to treat.
This module covers the common adverse reactions noted in the prescribing information for currently approved immunotherapeutic cancer agents.
START
Practical considerations for assessing response, managing toxicities
Sacituzumab govitecan appears safe, effective in heavily pretreated breast cancer subtype
L-glutamine reduces painful crises associated with sickle cell disease
Rucaparib induces response in BRCA-mutated pancreatic cancer
Learn. Research. Collaborate.
Begin your journey with Learn Immuno-Oncology. Test your knowledge and determine where to start.